[
  {
    "ts": null,
    "headline": "Are Hedge Funds Betting Big On AbbVie Inc. (ABBV)?",
    "summary": "We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other most promising healthcare stocks according to hedge funds. The Healthcare Sector: Growth, Innovation, and the Impact of AI The healthcare sector depends […]",
    "url": "https://finnhub.io/api/news?id=4b119b792bedeed94940bdbc42518769a6a61dd8cd686a88cbe28303ba604ec4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732375197,
      "headline": "Are Hedge Funds Betting Big On AbbVie Inc. (ABBV)?",
      "id": 131593592,
      "image": "https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other most promising healthcare stocks according to hedge funds. The Healthcare Sector: Growth, Innovation, and the Impact of AI The healthcare sector depends […]",
      "url": "https://finnhub.io/api/news?id=4b119b792bedeed94940bdbc42518769a6a61dd8cd686a88cbe28303ba604ec4"
    }
  },
  {
    "ts": null,
    "headline": "The Stock Market Is Soaring but These 2 Stocks Are Still Dirt Cheap Buys",
    "summary": "Earlier this month, the S&P 500 hit a record high of more than 6,000 for the first time ever.  Based on that, you might assume that stocks may be too expensive to buy right now as the average stock in the index is trading at more than 25 times earnings.  Two stocks that could be among the best bargains right now include AbbVie (NYSE: ABBV) and Comcast (NASDAQ: CMCSA).",
    "url": "https://finnhub.io/api/news?id=ca31ff4098b0e9bb0e626402e64d81978f360d41591a953f4ad73b51df6cf43e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732371420,
      "headline": "The Stock Market Is Soaring but These 2 Stocks Are Still Dirt Cheap Buys",
      "id": 131590157,
      "image": "https://g.foolcdn.com/editorial/images/798057/investor-at-home-looking-at-multiple-charts.jpg",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Earlier this month, the S&P 500 hit a record high of more than 6,000 for the first time ever.  Based on that, you might assume that stocks may be too expensive to buy right now as the average stock in the index is trading at more than 25 times earnings.  Two stocks that could be among the best bargains right now include AbbVie (NYSE: ABBV) and Comcast (NASDAQ: CMCSA).",
      "url": "https://finnhub.io/api/news?id=ca31ff4098b0e9bb0e626402e64d81978f360d41591a953f4ad73b51df6cf43e"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend Stocks That Are Screaming Buys in November",
    "summary": "Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.",
    "url": "https://finnhub.io/api/news?id=bfe5d35f7f82010912688c17a85fcfe376f612b1571478a9d4c58daf830f1988",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732364400,
      "headline": "3 Dividend Stocks That Are Screaming Buys in November",
      "id": 131588262,
      "image": "https://g.foolcdn.com/editorial/images/798476/healthcare-consulting.jpg",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.",
      "url": "https://finnhub.io/api/news?id=bfe5d35f7f82010912688c17a85fcfe376f612b1571478a9d4c58daf830f1988"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie upgraded to Outperform from Market Perform at Leerink",
    "summary": "Leerink analyst David Risinger upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target The firm recommends taking advantage of the emraclidine setback and election-related downdraft to purchase shares, and tells investors in a research note that while its financial projections are roughly in line with consensus, but Leerink sees the potential for continued strong execution to drive upside, including for Skyrizi in its recently-launched ulcerative colitis indication. Whi",
    "url": "https://finnhub.io/api/news?id=93db151df91f08ed03bbe1a7029ba20c9c209aaea19ad9e55923c1f4604da750",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732360851,
      "headline": "AbbVie upgraded to Outperform from Market Perform at Leerink",
      "id": 131586798,
      "image": "",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Leerink analyst David Risinger upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target The firm recommends taking advantage of the emraclidine setback and election-related downdraft to purchase shares, and tells investors in a research note that while its financial projections are roughly in line with consensus, but Leerink sees the potential for continued strong execution to drive upside, including for Skyrizi in its recently-launched ulcerative colitis indication. Whi",
      "url": "https://finnhub.io/api/news?id=93db151df91f08ed03bbe1a7029ba20c9c209aaea19ad9e55923c1f4604da750"
    }
  },
  {
    "ts": null,
    "headline": "Leerink Partners Upgrades AbbVie (ABBV)",
    "summary": "Leerink Partners Upgrades AbbVie (ABBV)",
    "url": "https://finnhub.io/api/news?id=e06065de747b419fa945e3e26744cdbb7101a2938d7391cb8a8e76ca01f2c332",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732320380,
      "headline": "Leerink Partners Upgrades AbbVie (ABBV)",
      "id": 131575303,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e06065de747b419fa945e3e26744cdbb7101a2938d7391cb8a8e76ca01f2c332"
    }
  }
]